Cite
HARVARD Citation
Chow, L. et al. (n.d.). 2866 Antitumor activity of the Anti-PD-1 antibody pembrolizumab in subgroups of patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): Exploratory analyses from KEYNOTE-012. European journal of cancer. pp. S579-. [Online].